
A series of ten novel chalcone incorporated quinazoline derivatives (11a-11j) were designed and synthesized. All the synthesized compounds were evaluated for their anticancer activities against four human cancer cell lines (A549, HT-29, MCF-7 and A375). Among them, four compounds, 11f, 11g, 11i and 11j showed more potent anticancer activity than the control drug, Combretastatin - A4.
Pharmacology, Cytotoxicity, Pharmaceutical Science, Gefitinib, RM1-950, Chalcones, Erlotinib, Resveratrol, Quinazolines, Original Article, Therapeutics. Pharmacology
Pharmacology, Cytotoxicity, Pharmaceutical Science, Gefitinib, RM1-950, Chalcones, Erlotinib, Resveratrol, Quinazolines, Original Article, Therapeutics. Pharmacology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 87 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
